ClinicalTrials.gg
RecruitingNCT07883122Updated Oct 23, 2026

Permanent Versus Slowly Dissolving Stitches for Non-Mesh (Shouldice) Groin Hernia Repair

An interventional study of Polypropylene suture (Prolene) and Polydioxanone suture (PDS) in Inguinal Hernia, sponsored by Northwestern University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Northwestern University · Not applicable, Interventional, and Treatment

Updated Oct 20, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn whether slowly dissolving stitches work as well as permanent stitches for repairing a groin (inguinal) hernia in adults using the Shouldice technique, a hernia repair that does not use mesh. Researchers think dissolving stitches may cause less long-term groin discomfort without making the hernia more likely to come back. The main questions it aims to answer are:

Is the chance of the hernia coming back within 1 year different with dissolving stitches (PDS) compared with permanent stitches (Prolene)?

Do the two types of stitches differ in complications, groin pain, quality of life, or the feeling of something foreign in the groin?

Is a larger future study of this question possible? This includes whether enough people join, whether the study plan is followed, and whether participants complete follow-up.

Researchers will compare slowly dissolving polydioxanone (PDS) stitches with permanent polypropylene (Prolene) stitches to see if the hernia comes back at similar rates and if patients have less long-term discomfort.

Participants will:

Have their planned open Shouldice hernia repair. The type of stitch will be chosen at random, like flipping a coin, during surgery.

Not be told which stitch they received until 1 year after surgery, or sooner if the hernia comes back or another operation is needed.

Complete questionnaires about pain, activity, and quality of life before surgery and about 30 days, 6 months, and 1 year after surgery.

See their surgeon for routine visits about 30 days and 1 year after surgery.

Receive one research phone call about 6 months after surgery.

Answer whether they feel something foreign in their groin and which type of stitch they think they received.

Read the detailed description

Background: The Shouldice repair is a non-mesh inguinal hernia repair that reconstructs the posterior inguinal wall in four continuous suture layers. It is traditionally performed with permanent suture. Permanent suture leaves foreign material in the groin that may contribute to foreign body sensation and chronic groin pain. Slowly absorbable polydioxanone retains tensile strength through the early healing period before it is absorbed. Stainless-steel sutures used in Shouldice repairs have been observed to fracture over time. This raises the possibility that permanent suture strength may not be required once tissue healing is complete.

Conduct: Randomization is centralized across all sites, using block randomization with a fixed block size of 4. It takes place intraoperatively after hernia dissection and sac reduction.

Analysis: The primary analysis is intention-to-treat. Feasibility is defined as successful delivery of the allocated repair with complete data collection in at least 80% of participants, considered acceptable if within 5 percentage points of that target. The trial is not powered for formal hypothesis testing of recurrence. Its purpose is to inform the design of a definitive multicenter non-inferiority trial.

Safety: Procedure- and suture-related adverse events are reviewed weekly by the investigators. No independent data monitoring committee is planned because both sutures are FDA-cleared and used on-label in an established operation. Enrollment will be suspended if a safety signal or a between-arm imbalance in recurrence or complications emerges.

02

Conditions studied

  • Inguinal Hernia

Browse trials for

Keywords

  • Shouldice repair
  • Non-mesh hernia repair
  • Polydioxanone (PDS)
  • Polypropylene (Prolene)
  • Absorbable suture
  • Hernia recurrence
03

In context

Hernia, Inguinal

561 studies on the registry are indexed under Hernia, Inguinal; 76 are open to participants now.

This study's planned enrollment of 200 is above the median of 90 across 414 interventional studies indexed under Hernia, Inguinal.

Browse Hernia, Inguinal studies →

Lead sponsor

Northwestern University is the lead sponsor of 1,420 studies on the registry; 199 are open to participants now.

Of its 103 completed or terminated interventional studies of FDA-regulated products, 75 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female patients 18 years or older
  • Symptomatic unilateral inguinal hernia
  • BMI 30 or less
  • Ability to provide informed consent
  • Must speak and understand English

Exclusion criteria

Exclusion Criteria:

  • Urgent or emergent presentations
  • Contaminated cases
  • Prior inguinal hernia repairs done on side of presenting symptomatic hernia
  • Femoral hernias
  • Adults unable to consent
  • Pregnant patients
  • Bilateral inguinal hernia repairs
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
200 participants (estimated)

Study arms

  • Active comparator
    Prolene

    Open Shouldice repair with all four layers closed using permanent polypropylene (Prolene) suture.

    Device: Polypropylene suture (Prolene)

  • Experimental
    PDS

    Open Shouldice repair with all four layers closed using slowly absorbable polydioxanone (PDS) suture.

    Device: Polydioxanone suture (PDS)

Interventions

  • DevicePolypropylene suture (Prolene)

    Permanent monofilament polypropylene suture used to complete all four layers of an open Shouldice inguinal hernia repair.

  • DevicePolydioxanone suture (PDS)

    Slowly absorbable monofilament polydioxanone suture used to complete all four layers of an open Shouldice inguinal hernia repair.

06

What researchers measure

Primary outcomes

  1. Number of Participants with Inguinal Hernia Recurrence

    Recurrent inguinal hernia identified on clinical examination and confirmed by imaging.

    Time frame: 1 year (+/- 2 months) after surgery

Secondary outcomes

  1. Postoperative Complications (wound complications, readmissions, reoperations)

    Postoperative complications, including wound complications, readmissions, and reoperations.

    Time frame: 30 days (+/- 15 days) and 1 year (+/- 2 months) after surgery

  2. EuraHS-QoL (European Registry for Abdominal Wall Hernias Quality of Life) Total Score

    Patient-reported quality of life measured with the European Registry for Abdominal Wall Hernias Quality of Life (EuraHS-QoL) score. The total score ranges from 0 to 90; higher scores indicate worse quality of life.

    Time frame: Baseline (preoperative), 30 days, 6 months, and 12 months after surgery

  3. EuraHS-QoL Pain Domain Score

    Groin pain measured with the pain domain of the EuraHS-QoL questionnaire (3 items). The domain score ranges from 0 to 30; higher scores indicate worse pain.

    Time frame: 6 and 12 months after surgery

  4. Number of Participants Reporting Foreign Body Sensation

    Number of participants reporting a foreign body sensation in the groin, assessed with a single yes/no question.

    Time frame: 30 days, 6 months, and 12 months after surgery

  5. Number of Participants Who Believe They Received Permanent Suture

    Participants are asked which suture type they believe was used in their repair.

    Time frame: 30 days, 6 months, and 12 months after surgery

  6. Enrollment Rate

    Mean number of participants randomized per month of active enrollment, from first to last randomization.

    Time frame: From study start through end of enrollment, approximately 12 months

  7. Number of Participants Receiving the Allocated Suture Repair

    Number of randomized participants whose Shouldice repair was completed using the allocated suture (Prolene or PDS) in all four layers.

    Time frame: Day of surgery

  8. Number of Participants Completing the 12-Month Recurrence Assessment and All Scheduled EuraHS-QoL Questionnaires

    Each participant is classified as having complete or incomplete follow-up. Complete follow-up requires both attendance at the 12-month visit with a hernia recurrence assessment and completion of the European Registry for Abdominal Wall Hernias Quality of Life (EuraHS-QoL) questionnaire at 30 days, 6 months, and 12 months. The total score for the EuraHS-QoL ranges from 0 to 90; higher scores indicate worse quality of life. The number of participants with complete follow-up is reported.

    Time frame: 12 months after surgery (+/- 2 months)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Paasch C, Mainprize M, Hunger R, Netto FACS. Polypropylene vs. stainless-steel wire suture: short-term recurrence rate after shouldice primary inguinal hernia repair, a non-inferior analysis among 1120 patients. A case-control study. Hernia. 2024 Dec;28(6):2177-2186. doi: 10.1007/s10029-024-03110-z. Epub 2024 Aug 29. PubMed 39210196 ↗
  • Mainprize M, Spencer Netto FAC, Degani C, Szasz P. The Shouldice Method: an expert's consensus. Hernia. 2023 Feb;27(1):147-156. doi: 10.1007/s10029-022-02658-y. Epub 2022 Aug 8. PubMed 35939246 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared publicly. Data will be used by the study team for analysis and reporting of aggregate results only.

09

Updates

2 registry updates since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 20, 2026
Show all 2 updates
  1. Oct 23, 2026
    Minor edits only
    + 1 other change: secondary outcomes
  2. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07883122
Responsible party
Megan Melland-Smith (Assistant Professor of Surgery, Northwestern University) — Principal investigator
First posted
Oct 20, 2026
Start date
Oct 2026 (estimated)
Primary completion
Dec 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Oct 23, 2026

Study contacts

Megan Melland-Smith, MD
Contact
megan.mellandsmith@nm.org
312-695-6868
Maria Narvaez Pereyra, MD
Contact
maria.narvaezpereyra@northwestern.edu
561-271-5655
Megan Melland-Smith, MD
principal investigator · Northwestern University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion